Aceragen (IDRA) – Hot FDA News
-
Idera Pharma (IDRA) Shares Positive Results from Investigator-Sponsored Trial in Melanoma Patients at Amsterdam UMC, Enrollment Stopped Early for Efficacy
-
Idera Pharma (IDRA) ILLUMINATE-301 Trial of Tilsotolimod + Ipilimumab in anti-PD-1 Refractory Advanced Melanoma Did Not Meet Its Primary Endpoint
-
-
-
-
Back to IDRA Stock Lookup
